Bridgeway Capital Management’s AN2 Therapeutics ANTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.5K | Hold |
59,900
| – | – | ﹤0.01% | 1119 |
|
|
2025
Q1 | $81.5K | Sell |
59,900
-102,300
| -63% | -$139K | ﹤0.01% | 1073 |
|
|
2024
Q4 | $224K | Sell |
162,200
-34,800
| -18% | -$48K | 0.01% | 980 |
|
|
2024
Q3 | $211K | Buy |
197,000
+92,708
| +89% | +$99.2K | ﹤0.01% | 1054 |
|
|
2024
Q2 | $224K | Buy |
104,292
+78,000
| +297% | +$168K | 0.01% | 1034 |
|
|
2024
Q1 | $85.4K | Sell |
26,292
-10,700
| -29% | -$34.8K | ﹤0.01% | 1223 |
|
|
2023
Q4 | $758K | Sell |
36,992
-10,508
| -22% | -$215K | 0.02% | 830 |
|
|
2023
Q3 | $764K | Buy |
47,500
+20,000
| +73% | +$322K | 0.02% | 778 |
|
|
2023
Q2 | $234K | Sell |
27,500
-25,000
| -48% | -$213K | 0.01% | 1098 |
|
|
2023
Q1 | $518K | Buy |
+52,500
| New | +$518K | 0.01% | 878 |
|